Vaccination with Plasmids Encoding the GP63 Glycoprotein and CD40L Results in a Partial Suppression of the Inflammatory Reaction after Experimental Infection

The development of an effective vaccine against leishmaniasis is the aim of an intensive research effort, to bring relief to thousands of people worldwide. DNA vaccination is a promising approach in this direction, since it is able to generate a strong cellular immune response. We tested whether the...

Full description

Bibliographic Details
Main Authors: P. Tsagozis, V. Tseveleki, L. Probert, E. Dotsika, E. Karagouni
Format: Article
Language:English
Published: SAGE Publishing 2004-05-01
Series:European Journal of Inflammation
Online Access:https://doi.org/10.1177/1721727X0400200207
_version_ 1811337832278523904
author P. Tsagozis
V. Tseveleki
L. Probert
E. Dotsika
E. Karagouni
author_facet P. Tsagozis
V. Tseveleki
L. Probert
E. Dotsika
E. Karagouni
author_sort P. Tsagozis
collection DOAJ
description The development of an effective vaccine against leishmaniasis is the aim of an intensive research effort, to bring relief to thousands of people worldwide. DNA vaccination is a promising approach in this direction, since it is able to generate a strong cellular immune response. We tested whether the co-administration of a plasmid encoding a truncated gp63 gene, that allows extracellular secretion of the encoded protein, and a plasmid encoding for CD40L could induce a protective response in genetically susceptible BALB/c mice and reduce the local inflammatory swelling after infection with Leishmania major . We document that vaccination with the combination of plasmids for gp63 and CD40L reduced inflammatory swelling, while vaccination with the truncated gp63-encoding plasmid resulted in an exacerbation of the local inflammatory reaction. These preliminary data indicate that the CD40L expression plasmid is consequently an efficient adjuvant for the induction of protective responses in the context of a DNA vaccination against leishmaniasis.
first_indexed 2024-04-13T18:01:40Z
format Article
id doaj.art-60129782893d41c29e895d4c1547316f
institution Directory Open Access Journal
issn 1721-727X
language English
last_indexed 2024-04-13T18:01:40Z
publishDate 2004-05-01
publisher SAGE Publishing
record_format Article
series European Journal of Inflammation
spelling doaj.art-60129782893d41c29e895d4c1547316f2022-12-22T02:36:14ZengSAGE PublishingEuropean Journal of Inflammation1721-727X2004-05-01210.1177/1721727X0400200207Vaccination with Plasmids Encoding the GP63 Glycoprotein and CD40L Results in a Partial Suppression of the Inflammatory Reaction after Experimental InfectionP. TsagozisV. Tseveleki0L. Probert1E. DotsikaE. Karagouni Laboratory of Molecular Genetics, Institut Pasteur Hellenique, Athens, Greece Laboratory of Molecular Genetics, Institut Pasteur Hellenique, Athens, GreeceThe development of an effective vaccine against leishmaniasis is the aim of an intensive research effort, to bring relief to thousands of people worldwide. DNA vaccination is a promising approach in this direction, since it is able to generate a strong cellular immune response. We tested whether the co-administration of a plasmid encoding a truncated gp63 gene, that allows extracellular secretion of the encoded protein, and a plasmid encoding for CD40L could induce a protective response in genetically susceptible BALB/c mice and reduce the local inflammatory swelling after infection with Leishmania major . We document that vaccination with the combination of plasmids for gp63 and CD40L reduced inflammatory swelling, while vaccination with the truncated gp63-encoding plasmid resulted in an exacerbation of the local inflammatory reaction. These preliminary data indicate that the CD40L expression plasmid is consequently an efficient adjuvant for the induction of protective responses in the context of a DNA vaccination against leishmaniasis.https://doi.org/10.1177/1721727X0400200207
spellingShingle P. Tsagozis
V. Tseveleki
L. Probert
E. Dotsika
E. Karagouni
Vaccination with Plasmids Encoding the GP63 Glycoprotein and CD40L Results in a Partial Suppression of the Inflammatory Reaction after Experimental Infection
European Journal of Inflammation
title Vaccination with Plasmids Encoding the GP63 Glycoprotein and CD40L Results in a Partial Suppression of the Inflammatory Reaction after Experimental Infection
title_full Vaccination with Plasmids Encoding the GP63 Glycoprotein and CD40L Results in a Partial Suppression of the Inflammatory Reaction after Experimental Infection
title_fullStr Vaccination with Plasmids Encoding the GP63 Glycoprotein and CD40L Results in a Partial Suppression of the Inflammatory Reaction after Experimental Infection
title_full_unstemmed Vaccination with Plasmids Encoding the GP63 Glycoprotein and CD40L Results in a Partial Suppression of the Inflammatory Reaction after Experimental Infection
title_short Vaccination with Plasmids Encoding the GP63 Glycoprotein and CD40L Results in a Partial Suppression of the Inflammatory Reaction after Experimental Infection
title_sort vaccination with plasmids encoding the gp63 glycoprotein and cd40l results in a partial suppression of the inflammatory reaction after experimental infection
url https://doi.org/10.1177/1721727X0400200207
work_keys_str_mv AT ptsagozis vaccinationwithplasmidsencodingthegp63glycoproteinandcd40lresultsinapartialsuppressionoftheinflammatoryreactionafterexperimentalinfection
AT vtseveleki vaccinationwithplasmidsencodingthegp63glycoproteinandcd40lresultsinapartialsuppressionoftheinflammatoryreactionafterexperimentalinfection
AT lprobert vaccinationwithplasmidsencodingthegp63glycoproteinandcd40lresultsinapartialsuppressionoftheinflammatoryreactionafterexperimentalinfection
AT edotsika vaccinationwithplasmidsencodingthegp63glycoproteinandcd40lresultsinapartialsuppressionoftheinflammatoryreactionafterexperimentalinfection
AT ekaragouni vaccinationwithplasmidsencodingthegp63glycoproteinandcd40lresultsinapartialsuppressionoftheinflammatoryreactionafterexperimentalinfection